Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors
BACKGROUND. It is not known whether the treatment of patients with asymptomatic left ventricular dysfunction reduces mortality and morbidity. We studied the effect of an angiotensin-converting--enzyme inhibitor, enalapril, on total mortality and mortality from cardiovascular causes, the development of heart failure, and hospitalization for heart failure among patients with ejection fractions of 0.35 or less who were not receiving drug treatment for heart failure. METHODS. Patients were randomly assigned to receive either placebo (n = 2117) or enalapril (n = 2111) at doses of 2.5 to 20 mg per day in a double-blind trial. Follow-up averaged 37.4 months. RESULTS. There were 334 deaths in the placebo group, as compared with 313 in the enalapril group (reduction in risk, 8 percent by the log-rank test; 95 percent confidence interval, -8 percent [an increase of 8 percent] to 21 percent; P = 0.30). The reduction in mortality from cardiovascular causes was larger but was not statistically significant (298 deaths in the placebo group vs. 265 in the enalapril group; risk reduction, 12 percent; 95 percent confidence interval, -3 to 26 percent; P = 0.12). When we combined patients in whom heart failure developed and those who died, the total number of deaths and cases of heart failure was lower in the enalapril group than in the placebo group (630 vs. 818; risk reduction, 29 percent; 95 percent confidence interval, 21 to 36 percent; P less than 0.001). In addition, fewer patients given enalapril died or were hospitalized for heart failure (434 in the enalapril group; vs. 518 in the placebo group; risk reduction, 20 percent; 95 percent confidence interval, 9 to 30 percent; P less than 0.001). CONCLUSIONS. The angiotensin-converting--enzyme inhibitor enalapril significantly reduced the incidence of heart failure and the rate of related hospitalizations, as compared with the rates in the group given placebo, among patients with asymptomatic left ventricular dysfunction. There was also a trend toward fewer deaths due to cardiovascular causes among the patients who received enalapril.
This article has been cited by other articles:
Sveen, M.-L., Thune, J. J., Kober, L., Vissing, J.
(2008). Cardiac Involvement in Patients With Limb-Girdle Muscular Dystrophy Type 2 and Becker Muscular Dystrophy. Arch Neurol
65: 1196-1201
[Abstract][Full Text]
Telli, M. L., Witteles, R. M., Fisher, G. A., Srinivas, S.
(2008). Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate. Ann Oncol
19: 1613-1618
[Abstract][Full Text]
Parish, R. C, Evans, J. D
(2008). Inflammation in Chronic Heart Failure. The Annals of Pharmacotherapy
42: 1002-1016
[Abstract][Full Text]
Femia, F. J., Maresca, K. P., Hillier, S. M., Zimmerman, C. N., Joyal, J. L., Barrett, J. A., Aras, O., Dilsizian, V., Eckelman, W. C., Babich, J. W.
(2008). Synthesis and Evaluation of a Series of 99mTc(CO)3+ Lisinopril Complexes for In Vivo Imaging of Angiotensin-Converting Enzyme Expression. JNM
49: 970-977
[Abstract][Full Text]
Cutler, J. A., Davis, B. R.
(2008). Thiazide-Type Diuretics and {beta}-Adrenergic Blockers as First-Line Drug Treatments for Hypertension. Circulation
117: 2691-2705
[Full Text]
Solski, L. V., Longyhore, D. S.
(2008). Prevention of type 2 diabetes mellitus with angiotensin-converting-enzyme inhibitors. Am J Health Syst Pharm
65: 935-940
[Abstract][Full Text]
Schrier, R. W.
(2008). Blood Urea Nitrogen and Serum Creatinine: Not Married in Heart Failure. Circ Heart Fail
1: 2-5
[Full Text]
Albert, N. M., Lewis, C.
(2008). Recognizing and Managing Asymptomatic Left Ventricular Dysfunction: After Myocardial Infarction. Crit Care Nurse
28: 20-37
[Full Text]
Aghasadeghi, K., Aslani, A.
(2008). Differentiation of Ischemic and Dilated Cardiomyopathy on Electrocardiograms. Asian Cardiovasc. Thorac. Ann.
16: 103-106
[Abstract][Full Text]
Torabi, A., Cleland, J. G.F., Khan, N. K., Loh, P. H., Clark, A. L., Alamgir, F., Caplin, J. L., Rigby, A. S., Goode, K.
(2008). The timing of development and subsequent clinical course of heart failure after a myocardial infarction. Eur Heart J
29: 859-870
[Abstract][Full Text]
Mahadevan, G, Davis, R C, Frenneaux, M P, Hobbs, F D R, Lip, G Y H, Sanderson, J E, Davies, M K
(2008). Left ventricular ejection fraction: are the revised cut-off points for defining systolic dysfunction sufficiently evidence based?. Heart
94: 426-428
[Full Text]
DeMaria, A. N.
(2008). Clinical trials and clinical judgment.. J Am Coll Cardiol
51: 1120-1122
[Full Text]
Gradman, A. H., Kad, R.
(2008). Renin inhibition in hypertension.. J Am Coll Cardiol
51: 519-528
[Abstract][Full Text]
Zannad, F., Stough, W. G., Pitt, B., Cleland, J. G.F., Adams, K. F., Geller, N. L., Torp-Pedersen, C., Kirwan, B.-A., Follath, F.
(2008). Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition. Eur Heart J
29: 413-421
[Abstract][Full Text]
van den Brink, O. W., Delbridge, L. M D., Pedrazzini, T., Rosenfeldt, F. L, Pepe, S.
(2007). Augmented myocardial methionine-enkephalin in a murine model of cardiac angiotensin II-overexpression. Journal of Renin-Angiotensin-Aldosterone System
8: 153-159
[Abstract]
Perez de Isla, L., Zamorano, J., Quezada, M., Almeria, C., Rodrigo, J. L., Serra, V., Garcia Rubira, J. C., Ortiz, A. F., Macaya, C.
(2007). Functional mitral regurgitation after a first non-ST-segment elevation acute coronary syndrome: contribution to congestive heart failure. Eur Heart J
28: 2866-2872
[Abstract][Full Text]
Mollema, S. A., Liem, S. S., Suffoletto, M. S., Bleeker, G. B., van der Hoeven, B. L., van de Veire, N. R., Boersma, E., Holman, E. R., van der Wall, E. E., Schalij, M. J., Gorcsan, J. III, Bax, J. J.
(2007). Left Ventricular Dyssynchrony Acutely After Myocardial Infarction Predicts Left Ventricular Remodeling. J Am Coll Cardiol
50: 1532-1540
[Abstract][Full Text]
Saha, S. A., Molnar, J., Arora, R. R.
(2007). Tissue ACE Inhibitors for Secondary Prevention of Cardiovascular Disease in Patients With Preserved Left Ventricular Function: A Pooled Meta-analysis of Randomized Placebo-controlled Trials. J CARDIOVASC PHARMACOL THER
12: 192-204
[Abstract]
Pitt, B.
(2007). Promise of Mineralocorticoid Receptor Blockade in Asymptomatic Left Ventricular Dysfunction. Hypertension
50: 461-462
[Full Text]
Telli, M. L., Hunt, S. A., Carlson, R. W., Guardino, A. E.
(2007). Trastuzumab-Related Cardiotoxicity: Calling Into Question the Concept of Reversibility. JCO
25: 3525-3533
[Abstract][Full Text]
Husser, O., Husser, D., Stridh, M., Sornmo, L., Corino, V. D.A., Mainardi, L. T., Lombardi, F., Klein, H. U., Olsson, S. B., Bollmann, A.
(2007). Exercise testing for non-invasive assessment of atrial electrophysiological properties in patients with persistent atrial fibrillation. Europace
9: 627-632
[Abstract][Full Text]
Rosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, J., Izzo, J. L. Jr, Kaplan, N. M., O'Connor, C. M., O'Gara, P. T., Oparil, S.
(2007). REPRINT Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Hypertension
50: e28-e55
[Full Text]
Mozaffarian, D., Anker, S. D., Anand, I., Linker, D. T., Sullivan, M. D., Cleland, J. G.F., Carson, P. E., Maggioni, A. P., Mann, D. L., Pitt, B., Poole-Wilson, P. A., Levy, W. C.
(2007). Prediction of Mode of Death in Heart Failure: The Seattle Heart Failure Model. Circulation
116: 392-398
[Abstract][Full Text]
Owens, D. S., Plehn, J. F.
(2007). Recognizing Unrecognized Risk: The Evolving Role of Ventricular Functional Assessment in Population-Based Studies. Circulation
116: 126-130
[Full Text]
Colucci, W. S., Kolias, T. J., Adams, K. F., Armstrong, W. F., Ghali, J. K., Gottlieb, S. S., Greenberg, B., Klibaner, M. I., Kukin, M. L., Sugg, J. E., on behalf of the REVERT Study Group,
(2007). Metoprolol Reverses Left Ventricular Remodeling in Patients With Asymptomatic Systolic Dysfunction: The REversal of VEntricular Remodeling with Toprol-XL (REVERT) Trial. Circulation
116: 49-56
[Abstract][Full Text]
Hammoud, R., Vaccari, C. S., Khan, B. V.
(2007). Letter by Hammoud et al Regarding Article "Prevention of High-Dose Chemotherapy-Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition". Circulation
115: e637-e637
[Full Text]
de Teresa, E., Gomez-Doblas, J. J., Lamas, G., Alzueta, J., Fernandez-Lozano, I., Cobo, E., Navarro, X., Navarro-Lopez, F., Stockburger, M.
(2007). Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: rationale and design of the PREVENT-HF study. Europace
9: 442-446
[Abstract][Full Text]
Johnson, M. J
(2007). Management of end stage cardiac failure. Postgrad. Med. J.
83: 395-401
[Abstract][Full Text]
Mitchell, G. F., Dunlap, M. E., Warnica, W., Ducharme, A., Arnold, J. M. O., Tardif, J.-C., Solomon, S. D., Domanski, M. J., Jablonski, K. A., Rice, M. M., Pfeffer, M. A., for the Prevention of Events With Angiotensin-Conv,
(2007). Long-Term Trandolapril Treatment Is Associated With Reduced Aortic Stiffness: The Prevention of Events With Angiotensin-Converting Enzyme Inhibition Hemodynamic Substudy. Hypertension
49: 1271-1277
[Abstract][Full Text]
Omland, T., Drazner, M. H., Ueland, T., Abedin, M., Murphy, S. A., Aukrust, P., de Lemos, J. A.
(2007). Plasma Osteoprotegerin Levels in the General Population: Relation to Indices of Left Ventricular Structure and Function. Hypertension
49: 1392-1398
[Abstract][Full Text]
Rosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, J., Izzo, J. L. Jr, Kaplan, N. M., O'Connor, C. M., O'Gara, P. T., Oparil, S.
(2007). Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation
115: 2761-2788
[Full Text]
Murphy, A., McMurray, J. J.V.
(2007). Heart failure: are we neglecting the silent majority?. Eur Heart J
28: 1047-1048
[Full Text]
Petrie, M. C., McMurray, J. J.V.
(2007). Dysglycemia and Heart Failure Hospitalization: What Is the Link?. Circulation
115: 1334-1335
[Full Text]
Ceconi, C., Fox, K. M., Remme, W. J., Simoons, M. L., Bertrand, M., Parrinello, G., Kluft, C., Blann, A., Cokkinos, D., Ferrari, R.
(2007). ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res
73: 237-246
[Abstract][Full Text]
Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., Stevenson, W.
(2006). The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions. Circulation
114: 2871-2891
[Full Text]
Granger, C. B.
(2006). Prediction and Prevention of Chemotherapy-Induced Cardiomyopathy: Can It Be Done?. Circulation
114: 2432-2433
[Full Text]
Cardinale, D., Colombo, A., Sandri, M. T., Lamantia, G., Colombo, N., Civelli, M., Martinelli, G., Veglia, F., Fiorentini, C., Cipolla, C. M.
(2006). Prevention of High-Dose Chemotherapy-Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition. Circulation
114: 2474-2481
[Abstract][Full Text]
Assomull, R. G., Prasad, S. K., Lyne, J., Smith, G., Burman, E. D., Khan, M., Sheppard, M. N., Poole-Wilson, P. A., Pennell, D. J.
(2006). Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy. J Am Coll Cardiol
48: 1977-1985
[Abstract][Full Text]
Skali, H., Pfeffer, M. A., Lubsen, J., Solomon, S. D.
(2006). Variable Impact of Combining Fatal and Nonfatal End Points in Heart Failure Trials. Circulation
114: 2298-2303
[Abstract][Full Text]
Pfeffer, M. A., Frohlich, E. D.
(2006). Improvements in clinical outcomes with the use of angiotensin-converting enzyme inhibitors: cross-fertilization between clinical and basic investigation. Am. J. Physiol. Heart Circ. Physiol.
291: H2021-H2025
[Abstract][Full Text]
Richard, P., Villard, E., Charron, P., Isnard, R.
(2006). The Genetic Bases of Cardiomyopathies. J Am Coll Cardiol
48: A79-A89
[Abstract][Full Text]
Gheorghiade, M., Sopko, G., De Luca, L., Velazquez, E. J., Parker, J. D., Binkley, P. F., Sadowski, Z., Golba, K. S., Prior, D. L., Rouleau, J. L., Bonow, R. O.
(2006). Navigating the Crossroads of Coronary Artery Disease and Heart Failure. Circulation
114: 1202-1213
[Full Text]
Kirby, M.
(2006). Heart failure and diabetes in primary care. British Journal of Diabetes & Vascular Disease
6: 220-228
[Abstract]
Dolezal, T.
(2006). Review: Imidapril in Heart Failure. Journal of Renin-Angiotensin-Aldosterone System
7: 146-154
[Abstract]
Writing Committee Members, , Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ACC/AHA Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L.
(2006). ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace
8: 651-745
[Full Text]
Hunt, S. A.
(2006). ACC/AHA guidelines: A-, B-, C-, and D-based approach to chronic heart failure therapy. Eur Heart J Suppl
8: E3-E5
[Abstract][Full Text]
Nair, A., Sealove, B., Halperin, J. L., Webber, G., Fuster, V.
(2006). Anticoagulation in patients with heart failure: who, when, and why?. Eur Heart J Suppl
8: E32-E38
[Abstract][Full Text]
Leenen, F. H.H., Nwachuku, C. E., Black, H. R., Cushman, W. C., Davis, B. R., Simpson, L. M., Alderman, M. H., Atlas, S. A., Basile, J. N., Cuyjet, A. B., Dart, R., Felicetta, J. V., Grimm, R. H., Haywood, L. J., Jafri, S. Z.A., Proschan, M. A., Thadani, U., Whelton, P. K., Wright, J. T., for the Antihypertensive and Lipid-Lowering Treatm,
(2006). Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Hypertension
48: 374-384
[Abstract][Full Text]
Tsuyuki, R. T., McDonald, M. A.
(2006). Response to Tsuyuki and McDonald. Circulation
114: 855-860
[Full Text]
Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S.
(2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society . J Am Coll Cardiol
48: e149-e246
[Full Text]
Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ACC/AHA TASK FORCE MEMBERS, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., ESC COMMITTEE FOR PRACTICE GUIDELINES, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L.
(2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation
114: e257-e354
[Full Text]
Neilan, T. G., Jassal, D. S., Perez-Sanz, T. M., Raher, M. J., Pradhan, A. D., Buys, E. S., Ichinose, F., Bayne, D. B., Halpern, E. F., Weyman, A. E., Derumeaux, G., Bloch, K. D., Picard, M. H., Scherrer-Crosbie, M.
(2006). Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury. Eur Heart J
27: 1868-1875
[Abstract][Full Text]
Solomon, S. D., Rice, M. M., A. Jablonski, K., Jose, P., Domanski, M., Sabatine, M., Gersh, B. J., Rouleau, J., Pfeffer, M. A., Braunwald, E., for the Prevention of Events with ACE inhibition (,
(2006). Renal Function and Effectiveness of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Chronic Stable Coronary Disease in the Prevention of Events with ACE inhibition (PEACE) Trial. Circulation
114: 26-31
[Abstract][Full Text]
Fernandes, V. R.S., Polak, J. F., Edvardsen, T., Carvalho, B., Gomes, A., Bluemke, D. A., Nasir, K., O'Leary, D. H., Lima, J. A.C.
(2006). Subclinical Atherosclerosis and Incipient Regional Myocardial Dysfunction in Asymptomatic Individuals: The Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol
47: 2420-2428
[Abstract][Full Text]
Goldberg, L. R., Jessup, M.
(2006). Stage B Heart Failure: Management of Asymptomatic Left Ventricular Systolic Dysfunction. Circulation
113: 2851-2860
[Full Text]
Lechat, P.
(2006). The evolution of heart failure management over recent decades: from CONSENSUS to CIBIS. Eur Heart J Suppl
8: C5-C12
[Abstract][Full Text]
Funck-Brentano, C.
(2006). Beta-blockade in CHF: from contraindication to indication. Eur Heart J Suppl
8: C19-C27
[Abstract][Full Text]
Follath, F.
(2006). Beta-blockade today: the gap between evidence and practice. Eur Heart J Suppl
8: C28-C34
[Abstract][Full Text]
Ponikowski, P.
(2006). Rationale and design of CIBIS III. Eur Heart J Suppl
8: C35-C42
[Abstract][Full Text]
Grobe, J. L., Mecca, A. P., Mao, H., Katovich, M. J.
(2006). Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. Am. J. Physiol. Heart Circ. Physiol.
290: H2417-H2423
[Abstract][Full Text]
Ahn, S. A., Jong, P., Yusuf, S., Bangdiwala, S. I., Pouleur, H. G., Rousseau, M. F.
(2006). Early Versus Delayed Enalapril in Patients With Left Ventricular Systolic Dysfunction: Impact on Morbidity and Mortality 15 Years After the SOLVD Trial. J Am Coll Cardiol
47: 1904-1905
[Full Text]
Al-Mallah, M. H., Tleyjeh, I. M., Abdel-Latif, A. A., Weaver, W. D.
(2006). Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Coll Cardiol
47: 1576-1583
[Abstract][Full Text]
Volpe, M., Tocci, G., Pagannone, E.
(2006). Fewer Mega-Trials and More Clinically Oriented Studies in Hypertension Research? The Case of Blocking the Renin-Angiotensin-Aldosterone System.. J. Am. Soc. Nephrol.
17: S36-S43
[Abstract][Full Text]
Bhatia, G. S., Sosin, M. D., Patel, J. V., Grindulis, K. A., Khattak, F. H., Hughes, E. A., Lip, G. Y.H., Davis, R. C.
(2006). Left Ventricular Systolic Dysfunction in Rheumatoid Disease: An Unrecognized Burden?. J Am Coll Cardiol
47: 1169-1174
[Abstract][Full Text]
Heinze, G., Mitterbauer, C., Regele, H., Kramar, R., Winkelmayer, W. C., Curhan, G. C., Oberbauer, R.
(2006). Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Type 1 Receptor Antagonist Therapy Is Associated with Prolonged Patient and Graft Survival after Renal Transplantation. J. Am. Soc. Nephrol.
17: 889-899
[Abstract][Full Text]
Krumholz, H. M., Anderson, J. L., Brooks, N. H., Fesmire, F. M., Lambrew, C. T., Landrum, M. B., Weaver, W. D., Whyte, J., Bonow, R. O., Bennett, S. J., Burke, G., Eagle, K. A., Krumholz, H. M., Lambrew, C. T., Linderbaum, J., Masoudi, F. A., Normand, S.-L. T., PiNa, I. L., Radford, M. J., Rumsfeld, J. S., Ritchie, J. L., Spertus, J. A.
(2006). ACC/AHA Clinical Performance Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol
47: 236-265
[Full Text]
Schrier, R. W.
(2006). Role of Diminished Renal Function in Cardiovascular Mortality: Marker or Pathogenetic Factor?. J Am Coll Cardiol
47: 1-8
[Abstract][Full Text]
Edvardsen, T., Detrano, R., Rosen, B. D., Carr, J. J., Liu, K., Lai, S., Shea, S., Pan, L., Bluemke, D. A., Lima, J. A.C.
(2006). Coronary Artery Atherosclerosis Is Related to Reduced Regional Left Ventricular Function in Individuals Without History of Clinical Cardiovascular Disease: The Multiethnic Study of Atherosclerosis. Arterioscler. Thromb. Vasc. Bio.
26: 206-211
[Abstract][Full Text]
Ward, R. P., Don, C. W., Furlong, K. T., Lang, R. M.
(2006). Predictors of Long-Term Mortality in Patients With Ischemic Stroke Referred for Transesophageal Echocardiography. Stroke
37: 204-208
[Abstract][Full Text]
Aronow, W. S.
(2005). Drug Treatment of Systolic and of Diastolic Heart Failure in Elderly Persons. J. Gerontol. A Biol. Sci. Med. Sci.
60: 1597-1605
[Abstract][Full Text]
Prepared by: British Cardiac Society, British Hype,
(2005). JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart
91: v1-v52
[Full Text]
Remme, W. J., McMurray, J. J.V., Rauch, B., Zannad, F., Keukelaar, K., Cohen-Solal, A., Lopez-Sendon, J., Hobbs, F.D. R., Grobbee, D. E., Boccanelli, A., Cline, C., Macarie, C., Dietz, R., Ruzyllo, W.
(2005). Public awareness of heart failure in Europe: first results from SHAPE. Eur Heart J
26: 2413-2421
[Abstract][Full Text]
Dore, A., Houde, C., Chan, K.-L., Ducharme, A., Khairy, P., Juneau, M., Marcotte, F., Mercier, L.-A.
(2005). Angiotensin Receptor Blockade and Exercise Capacity in Adults With Systemic Right Ventricles: A Multicenter, Randomized, Placebo-Controlled Clinical Trial. Circulation
112: 2411-2416
[Abstract][Full Text]
McDonald, M. A, Simpson, S. H, Ezekowitz, J. A, Gyenes, G., Tsuyuki, R. T
(2005). Angiotensin receptor blockers and risk of myocardial infarction: systematic review. BMJ
331: 873-
[Abstract][Full Text]
Shah, A. D., Arora, R. R.
(2005). Do All Patients With Coronary Artery Disease Benefit from Angiotensin Converting Enzyme Inhibitors?. J CARDIOVASC PHARMACOL THER
10: 281-283
[Abstract]
Meune, C., Allanore, Y., Pascal, O., Devaux, J.-Y., Dessault, O., Duboc, D., Weber, S., Kahan, A.
(2005). Myocardial contractility is early affected in systemic sclerosis: A Tissue Doppler echocardiography study. Eur J Echocardiogr
6: 351-357
[Abstract][Full Text]
Developed in Collaboration With the American Colle, , Endorsed by the Heart Rhythm Society, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W., Antman, E. M., Smith, S. C. Jr, Adams, C. D., Anderson, J. L., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Jacobs, A. K., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2005). ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol
46: 1116-1143
[Full Text]
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W., Antman, E. M., Smith, S. C. Jr, Adams, C. D., Anderson, J. L., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Jacobs, A. K., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2005). ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation
112: 1825-1852
[Full Text]
Lee, D. S., Tu, J. V., Juurlink, D. N., Alter, D. A., Ko, D. T., Austin, P. C., Chong, A., Stukel, T. A., Levy, D., Laupacis, A.
(2005). Risk-Treatment Mismatch in the Pharmacotherapy of Heart Failure. JAMA
294: 1240-1247
[Abstract][Full Text]
HOPE/HOPE-TOO Study Investigators,
(2005). Long-Term Effects of Ramipril on Cardiovascular Events and on Diabetes: Results of the HOPE Study Extension. Circulation
112: 1339-1346
[Abstract][Full Text]
Mahon, N. G., Murphy, R. T., MacRae, C. A., Caforio, A. L.P., Elliott, P. M., McKenna, W. J.
(2005). Echocardiographic Evaluation in Asymptomatic Relatives of Patients with Dilated Cardiomyopathy Reveals Preclinical Disease. ANN INTERN MED
143: 108-115
[Abstract][Full Text]
Daly, C. A., Fox, K. M., Remme, W. J., Bertrand, M. E., Ferrari, R., Simoons, M. L., on behalf of the EUROPA investigators,
(2005). The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy. Eur Heart J
26: 1369-1378
[Abstract][Full Text]
Lehnart, S. E., Wehrens, X. H.T., Marks, A. R.
(2005). Defective Ryanodine Receptor Interdomain Interactions May Contribute to Intracellular Ca2+ Leak: A Novel Therapeutic Target in Heart Failure. Circulation
111: 3342-3346
[Full Text]
Authors/Task Force Members, , Swedberg, K., Writing Committee:, , Cleland, J., Dargie, H., Drexler, H., Follath, F., Komajda, M., Tavazzi, L., Smiseth, O. A., Other Contributors, , Gavazzi, A., Haverich, A., Hoes, A., Jaarsma, T., Korewicki, J., Levy, S., Linde, C., Lopez-Sendon, J.-L., Nieminen, M. S., Pierard, L., Remme, W. J.
(2005). Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J
26: 1115-1140
[Full Text]
Mann, D. L., Bristow, M. R.
(2005). Mechanisms and Models in Heart Failure: The Biomechanical Model and Beyond. Circulation
111: 2837-2849
[Full Text]
Nopmaneejumruslers, C., Kaneko, Y., Hajek, V., Zivanovic, V., Bradley, T. D.
(2005). Cheyne-Stokes Respiration in Stroke: Relationship to Hypocapnia and Occult Cardiac Dysfunction. Am. J. Respir. Crit. Care Med.
171: 1048-1052
[Abstract][Full Text]